Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitogilun Malate + Amlodipine in Mild to Moderate Essential Hypertension
NCT07876544Phase 4Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of sitokiren in essential hypertension, sponsored by Shanghai Jiao Tong University School of Medicine. Started Sep 2026; status: recruiting.
02
Drugs
sitokiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT07876544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876544.